Coleman RE - Search Results

1

High dose pamidronate: clinical and biochemical effects in metastatic bone disease.

Coleman RE, Purohit OP, Vinholes JJ, Zekri J. Coleman RE, et al. Cancer. 1997 Oct 15;80(8 Suppl):1686-90. doi: 10.1002/(sici)1097-0142(19971015)80:8+<1686::aid-cncr20>3.3.co;2-t. Cancer. 1997. PMID: 9362437 Clinical Trial.

2

Preliminary results of the use of urinary excretion of pyridinium crosslinks for monitoring metastatic bone disease.

Coleman RE, Houston S, James I, Rodger A, Rubens RD, Leonard RC, Ford J. Coleman RE, et al. Br J Cancer. 1992 May;65(5):766-8. doi: 10.1038/bjc.1992.161. Br J Cancer. 1992. PMID: 1586605 Free PMC article.

3

Bisphosphonate treatment of bone metastases and hypercalcemia of malignancy.

Coleman RE. Coleman RE. Oncology (Williston Park). 1991 Aug;5(8):55-60; discussion 60-2, 65. Oncology (Williston Park). 1991. PMID: 1834153

4

Treatment of bone metastases from breast cancer with (3-amino-1-hydroxypropylidene)-1,1-bisphosphonate (APD).

Coleman RE, Woll PJ, Miles M, Scrivener W, Rubens RD. Coleman RE, et al. Br J Cancer. 1988 Nov;58(5):621-5. doi: 10.1038/bjc.1988.272. Br J Cancer. 1988. PMID: 3219273 Free PMC article.

5

Osteocalcin: a potential marker of metastatic bone disease and response to treatment.

Coleman RE, Mashiter G, Fogelman I, Whitaker KD, Caleffi M, Moss DW, Rubens RD. Coleman RE, et al. Eur J Cancer Clin Oncol. 1988 Jul;24(7):1211-7. doi: 10.1016/0277-5379(88)90130-7. Eur J Cancer Clin Oncol. 1988. PMID: 3262063

6

Biochemical prediction of response of bone metastases to treatment.

Coleman RE, Whitaker KB, Moss DW, Mashiter G, Fogelman I, Rubens RD. Coleman RE, et al. Br J Cancer. 1988 Aug;58(2):205-10. doi: 10.1038/bjc.1988.194. Br J Cancer. 1988. PMID: 3262366 Free PMC article.

7

3(Amino-1,1-hydroxypropylidene) bisphosphonate (APD) for hypercalcaemia of breast cancer.

Coleman RE, Rubens RD. Coleman RE, et al. Br J Cancer. 1987 Oct;56(4):465-9. doi: 10.1038/bjc.1987.225. Br J Cancer. 1987. PMID: 3689664 Free PMC article.

8

A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.

Purohit OP, Radstone CR, Anthony C, Kanis JA, Coleman RE. Purohit OP, et al. Among authors: coleman re. Br J Cancer. 1995 Nov;72(5):1289-93. doi: 10.1038/bjc.1995.502. Br J Cancer. 1995. PMID: 7577484 Free PMC article. Clinical Trial.

9

High-dose intravenous pamidronate for metastatic bone pain.

Purohit OP, Anthony C, Radstone CR, Owen J, Coleman RE. Purohit OP, et al. Among authors: coleman re. Br J Cancer. 1994 Sep;70(3):554-8. doi: 10.1038/bjc.1994.344. Br J Cancer. 1994. PMID: 8080746 Free PMC article. Clinical Trial.

10

Treatment of malignant hypercalcaemia with aminohexane bisphosphonate (neridronate).

O'Rourke NP, McCloskey EV, Rosini S, Coleman RE, Kanis JA. O'Rourke NP, et al. Among authors: coleman re. Br J Cancer. 1994 May;69(5):914-7. doi: 10.1038/bjc.1994.176. Br J Cancer. 1994. PMID: 8180023 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,031 results

Search Page

Filters